Public trial registry of the CCC-Munich

Trial PCYC-1104-CA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
PCYC-1104-CA
World
Full title
:

Multizentrische Phase-2-Studie des Bruton-Tyrosinkinase (Btk) -Inhibitors PCI-32765 bei rezidiviertem oder refraktärem Zellzelllymphom

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C83.8 Sonstige nicht follikuläre Lymphome
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2014-01-31 / Unknown
Participants
Function Prename Surname Organization
World Principal Investigator MICHAEL UNTERHALT Keine Organisationseinheit angegeben Magnifier